Shenglan Li Selected Research

hepatic stimulator substance

8/2015	Amelioration of nonalcoholic fatty liver disease by hepatic stimulator substance via preservation of carnitine palmitoyl transferase-1 activity.
9/2011	Administration of naked plasmid encoding hepatic stimulator substance by hydrodynamic tail vein injection protects mice from hepatic failure by suppressing the mitochondrial permeability transition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shenglan Li Research Topics

Disease

6	Glioma (Gliomas) 02/2022 - 11/2016
6	Neoplasms (Cancer) 11/2021 - 11/2016
3	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 11/2016
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 12/2019
2	Fibrosis (Cirrhosis) 01/2020 - 01/2019
2	Infections 08/2019 - 11/2016
2	Lung Neoplasms (Lung Cancer) 05/2019 - 01/2019
2	Inflammation (Inflammations) 01/2019 - 05/2017
2	Allergic Rhinitis 02/2016 - 04/2015
1	Medulloblastoma 01/2022
1	Schizophrenia (Dementia Praecox) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2017
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2017
1	Virus Diseases (Viral Diseases) 11/2016
1	Encephalitis (Encephalitis, Rasmussen) 11/2016
1	Conjunctivitis 02/2016
1	Non-alcoholic Fatty Liver Disease 08/2015
1	Rhinosinusitis 03/2014
1	Nasal Polyps (Nasal Polyp) 03/2014
1	Acute Liver Failure (Fulminant Hepatic Failure) 09/2011
1	Liver Failure 09/2011

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 02/2022 - 11/2016
2	liposomal honokiolIBA 01/2022 - 11/2021
2	LipopolysaccharidesIBA 11/2021 - 09/2011
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2020 - 01/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 11/2016
2	Therapeutic UsesIBA 05/2017 - 02/2016
2	hepatic stimulator substanceIBA 08/2015 - 09/2011
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2021
1	InterleukinsIBA 11/2021
1	honokiolIBA 11/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 03/2020
1	CholesterolIBA 03/2020
1	Biological ProductsIBA 01/2020
1	TetraspaninsIBA 01/2020
1	CateninsIBA 12/2019
1	Doxycycline (Periostat)FDA LinkGeneric 08/2019
1	Amoxicillin (Wymox)FDA LinkGeneric 08/2019
1	BismuthIBA 08/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2019
1	CytokinesIBA 01/2019
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2019
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2019
1	PaxillinIBA 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019
1	5- methyl- 1- (3- fluorophenyl)- 2- (1H)- pyridoneIBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	IronIBA 01/2018
1	nucleotidaseIBA 01/2018
1	3'-nucleotidaseIBA 01/2018
1	NucleotidesIBA 01/2018
1	SulfurIBA 01/2018
1	PolyketidesIBA 01/2018
1	Capsules (Microcapsules)IBA 05/2017
1	Adenine FDA LinkGeneric 05/2017
1	Melanins (Melanin)IBA 05/2017
1	Metformin (Glucophage)FDA LinkGeneric 11/2016
1	Messenger RNA (mRNA)IBA 11/2016
1	Interferon Type IIBA 11/2016
1	Antiviral Agents (Antivirals)IBA 11/2016
1	Neutralizing AntibodiesIBA 11/2016
1	Carnitine (L-Carnitine)FDA LinkGeneric 08/2015
1	GlucocorticoidsIBA 03/2014
1	GalactosamineIBA 09/2011

Therapy/Procedure

2	Therapeutics 08/2019 - 01/2017
2	Immunotherapy 02/2016 - 04/2015
1	Intraperitoneal Injections 01/2019
1	Oral Administration 05/2017